Journal of cardiovascular echography · 2026
Deferred versus Immediate Stenting in ST-segment Elevation Myocardial Infarction Patients with High Thrombus Burden: A Randomized Clinical Trial Using Three-dimensional Speckle Tracking Echocardiography.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eldamanhory Ahmed Saeid, Mosa Hesham Hafez Abdelkhalek, Soliman Mahmoud Elsaid, Awadi Mohamed Ibrahim, Roshdy Hisham Samir, Shehata Islam Elsayed
Аннотация
OBJECTIVES: The optimal timing of stent implantation in ST-segment elevation myocardial infarction (STEMI) with high thrombus burden remains uncertain. Immediate stenting carries a risk of distal embolization and no-reflow, whereas deferred stenting may facilitate improved microvascular recovery. This study compared angiographic and echocardiographic outcomes of immediate versus deferred stenting using three-dimensional speckle tracking echocardiography (3D-STE).
MATERIALS AND METHODS: In this randomized clinical trial, 115 STEMI patients with high thrombus burden were allocated to immediate stenting (n = 60) or deferred stenting after dual antiplatelet therapy plus enoxaparin (n = 55). Primary endpoints were final thrombolysis in myocardial infarction (TIMI) flow, myocardial blush grade (MBG), and left ventricular ejection fraction (LVEF) by 3D-STE. Secondary endpoints included global strain parameters and major adverse cardiovascular events (MACE) at 6 months.
RESULTS: Deferred stenting achieved higher TIMI III flow (76.4% vs. 60.0%, P < 0.001) and MBG 3 (63.6% vs. 41.7%, P = 0.0025). Both groups showed improved LVEF at 6 months, with greater gains in the deferred group (EF change: 14.05% vs. 12.89%, P = 0.043). Favorable but nonsignificant trends were noted in global longitudinal, circumferential, and radial strain. MACE rates were similar between groups (34.5% vs. 41.7%, P = 0.45).
CONCLUSIONS: Deferred stenting in STEMI patients with high thrombus burden enhanced angiographic reperfusion and improved recovery of left ventricular function without reducing short-term MACE. These findings suggest deferred stenting as a feasible strategy to optimize myocardial reperfusion, warranting larger, long-term trials to evaluate its prognostic impact.
MATERIALS AND METHODS: In this randomized clinical trial, 115 STEMI patients with high thrombus burden were allocated to immediate stenting (n = 60) or deferred stenting after dual antiplatelet therapy plus enoxaparin (n = 55). Primary endpoints were final thrombolysis in myocardial infarction (TIMI) flow, myocardial blush grade (MBG), and left ventricular ejection fraction (LVEF) by 3D-STE. Secondary endpoints included global strain parameters and major adverse cardiovascular events (MACE) at 6 months.
RESULTS: Deferred stenting achieved higher TIMI III flow (76.4% vs. 60.0%, P < 0.001) and MBG 3 (63.6% vs. 41.7%, P = 0.0025). Both groups showed improved LVEF at 6 months, with greater gains in the deferred group (EF change: 14.05% vs. 12.89%, P = 0.043). Favorable but nonsignificant trends were noted in global longitudinal, circumferential, and radial strain. MACE rates were similar between groups (34.5% vs. 41.7%, P = 0.45).
CONCLUSIONS: Deferred stenting in STEMI patients with high thrombus burden enhanced angiographic reperfusion and improved recovery of left ventricular function without reducing short-term MACE. These findings suggest deferred stenting as a feasible strategy to optimize myocardial reperfusion, warranting larger, long-term trials to evaluate its prognostic impact.